NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

癌症生物學的療法市場 - 預測,各地區、主要國家市場分析,主要企業,COVID-19復甦方案:2021年∼2031年

Cancer Biologics Therapies Market Report 2021-2031: Forecasts by Treatment, by Product, by Indication, by Biologic Drugs, by End-user, Regional & Leading National Market Analysis, Leading Cancer Biologics Companies, and COVID-19 Recovery Scenarios

出版商 Visiongain Ltd 商品編碼 1015899
出版日期 內容資訊 英文 478 Pages
商品交期: 最快1-2個工作天內
價格
癌症生物學的療法市場 - 預測,各地區、主要國家市場分析,主要企業,COVID-19復甦方案:2021年∼2031年 Cancer Biologics Therapies Market Report 2021-2031: Forecasts by Treatment, by Product, by Indication, by Biologic Drugs, by End-user, Regional & Leading National Market Analysis, Leading Cancer Biologics Companies, and COVID-19 Recovery Scenarios
出版日期: 2021年04月01日內容資訊: 英文 478 Pages
簡介

由於確立的醫療基礎設施和生物醫藥品企業的存在,北美的癌症生物學的療法市場預計今後更加擴大。亞太地區,強化醫療產業的政府舉措增加,慢性疾病的盛行率上升,新興經濟國的醫療支出增加等,預計促進在預測期間內的癌症生物學的療法市場。

本報告提供全球癌症生物學的療法市場相關調查分析,市場動態,各市場區隔的市場分析,各地區、主要國家的市場分析,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 癌症生物學的療法市場簡介

  • 癌症生物學的療法市場定義
  • 癌症生物學的療法產業所使用的治療方法
    • 化療
    • 標靶治療
    • 免疫療法
    • 荷爾蒙療法
  • 癌症生物學的療法產業:各適應症
    • 乳癌
    • 子宮頸癌症
    • 結腸癌症、直腸癌症
    • 胃癌
    • 肺癌症
    • 卵巢癌症
    • 腎細胞癌症
    • 黑色素瘤

第3章 癌症生物學的療法市場概要

  • 全球腫瘤學支出市場規模,市場分析與預測
  • 世界、地區的癌症生物學的療法市場
  • 市場動態
  • 癌症生物學的療法市場:SWOT分析
  • 癌症生物學的療法市場:波特的五力分析
  • 歐洲的腫瘤學市場趨勢
  • 歐洲的疾病的得病率和發生率
  • Bevacizumab和Trastuzumab的處方分佈
  • EMA的認證,獨佔權的喪失,生物相似藥的影響分析的簡介
  • Bevacizumab和Trastuzumab的治療方案
  • 患者中退比率
  • 生物相似藥相關腫瘤學家的認識
  • 對生物學的治療的障礙與市場的廉價選擇的預期影響
  • 開發中的生物相似藥和R&D生物製藥

第4章 全球癌症生物學的療法市場分析與預測:各治療類型

  • 化療
  • 標靶治療
  • 免疫療法
  • 荷爾蒙療法
  • 其他

第5章 全球癌症生物學的療法市場分析與預測:各適應症

  • 乳癌
  • 子宮頸癌症
  • 結腸癌症、直腸癌症
  • 胃癌
  • 肺癌症
  • 卵巢癌症
  • 腎細胞癌症
  • 黑色素瘤
  • 其他

第6章 全球癌症生物學的療法市場分析與預測:各生物製藥

  • Bevacizumab
  • Trastuzumab
  • Trastuzumab emtansine
  • Pertuzumab
  • Rituximab
  • Cetuximab
  • Panitumumab
  • Ramucirumab
  • Necitumumab
  • PEMBROLIZUMAB
  • Atezolizumab
  • Durvalumab
  • Nivolumab
  • Ipilimumab

第7章 全球癌症生物學的療法市場分析與預測:各產品

  • 單株抗體
  • 細胞激素
  • 癌症增生阻滯劑
  • 疫苗
  • 血球成長因素
  • 其他

第8章 全球癌症生物學的療法市場分析與預測:各終端用戶

  • 醫院
  • 專門診所
  • 癌症、放射治療中心

第9章 北美的癌症生物學的療法市場分析與預測

第10章 歐洲的癌症生物學的療法市場分析與預測

第11章 亞太地區的癌症生物學的療法市場分析與預測

第12章 南美的癌症生物學的療法市場分析與預測

第13章 中東、非洲的癌症生物學的療法市場分析與預測

第14章 企業簡介

  • AbbVie Inc.
  • F.Hoffman La Roche
  • GlaxoSmithKline
  • Eli Lilly and Company
  • Amgen
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • GE Healthcare
  • Illumina
  • Qiagen N.V.
  • Biocept
  • Guardant Health

第15章 結論

目錄
Product Code: PHA1122

Title:
Cancer Biologics Therapies Market Report 2021-2031
Forecasts by Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Product (Monoclonal Antibodies, Cytokines, Cancer Growth Blockers, Vaccines, Blood Cell Growth Factors, and Others), by Indication (Breast Cancer, Cervical Cancer, Colon and Rectal Cancer, Gastric Cancer, Lung Cancer, Ovarian Cancer, Renal Cell Cancer, Melanoma), by Biologic Drugs (Bevacizumab, Trastuzumab, Trastuzumab Emtansine, Pertuzumab, Rituximab, Cetuximab, Panitumumab, Ramucirumab, Necitumumab, Pembrolizumab, Atezolizumab, Durvalumab, Nivolumab, Ipilimumab), by End-user (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cancer Biologics Companies AND COVID-19 Recovery Scenarios.

This report is intended to provide an in-depth analysis of the latest trends prevailing in the cancer biologics therapy market and its growth and development in the next decade. The changing demographics of the world population, increasing cancer prevalence, developing healthcare infrastructure, emerging economies, consumer spending behaviour, per capita income, macroeconomic factors, rising GDPs, and the reformation in laws and regulations are trend setting factors, which will affect the market.

Cancer Biologics Therapy Market: Regional Landscape

Presence of well-established healthcare infrastructure and biopharmaceutical companies are expected to further strengthen North America cancer biologics therapy market in coming years. Increasing government initiatives to strengthen healthcare industry, rising prevalence of chronic diseases, followed by increasing healthcare expenditure in emerging economies are expected to drive Asia Pacific cancer biologics therapy market over the forecast period.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

What are the Market Driving Factors?

  • Rising Cancer Prevalence Worldwide
  • Increasing Ageing Population in Developed as well as Developing Economies

Key Challenges for Cancer Biologics Therapy Market

  • Shortage of Skilled Workforce in the Biopharmaceutical Industry
  • High Cost Associated with Biopharmaceutical Drug Manufacturing

What are the Market Opportunities?

  • Increasing R&D Spending of Biopharmaceutical Companies
  • Future Perspective in Oncology Industry

Why you Should buy this Report?

Apart from market estimation and forecast to 2031 the report covers below mentioned important factors to offer in-depth analysis of cancer biologics industry.

  • SWOT Analysis
  • Porter's Five Forces Model
  • Oncology Market Trends
  • Global Oncology Spending, 2016 - 2031
  • Disease Prevalence and Incidence in Europe by Country
  • EMA Approved Biologics in Oncology
  • Biosimilars and R&D Biologics in Development

What are the Leading Companies Operating in the Market?

  • AbbVie Inc
  • F.Hoffman La Roche
  • GlaxoSmithKline
  • Eli Lilly and Company
  • Amgen
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories
  • GE Healthcare
  • Illumina
  • Qiagen N.V.
  • Biocept
  • Guardant Health

Market Segmentation and Scope

Cancer Biologics Therapy Market by Treatment

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

Cancer Biologics Therapy Market by Indication

  • Breast cancer
  • Cervical cancer
  • Colon and rectal cancer
  • Gastric cancer
  • Lung cancer
  • Ovarian cancer
  • Renal cell cancer
  • Melanoma

Cancer Biologics Therapy Market by Biologic Drug

  • Bevacizumab
  • Trastuzumab
  • Trastuzumab emtansine
  • Pertuzumab
  • Rituximab
  • Cetuximab
  • Panitumumab
  • Ramucirumab
  • Necitumumab
  • Pembrolizumab
  • Atezolizumab
  • Durvalumab
  • Nivolumab
  • Ipilimumab

Cancer Biologics Therapy Market by End User

  • Hospitals
  • Specialty Clinics
  • Cancer and Radiation Therapy Centers

Cancer Biologics Therapy Market by Product

  • Monoclonal Antibodies
  • Cytokines
  • Cancer Growth Blockers
  • Vaccines
  • Blood Cell Growth Factors
  • Others

Cancer Biologics Therapy Market by Region

  • North America Cancer Biologics Therapy Market
  • U.S. Cancer Biologics Therapy Market
  • Canada Cancer Biologics Therapy Market
  • Europe Cancer Biologics Therapy Market
  • UK Cancer Biologics Therapy Market
  • Germany Cancer Biologics Therapy Market
  • France Cancer Biologics Therapy Market
  • Italy Cancer Biologics Therapy Market
  • Spain Cancer Biologics Therapy Market
  • Portugal Cancer Biologics Therapy Market
  • Poland Cancer Biologics Therapy Market
  • Hungary Cancer Biologics Therapy Market
  • Czech Republic Cancer Biologics Therapy Market
  • Slovakia Cancer Biologics Therapy Market
  • Slovenia Cancer Biologics Therapy Market
  • Romania Cancer Biologics Therapy Market
  • Bulgaria Cancer Biologics Therapy Market
  • Croatia Cancer Biologics Therapy Market
  • Baltic States Cancer Biologics Therapy Market
  • Serbia Cancer Biologics Therapy Market
  • Asia Pacific Cancer Biologics Therapy Market
  • China Cancer Biologics Therapy Market
  • Japan Cancer Biologics Therapy Market
  • India Cancer Biologics Therapy Market
  • Australia Cancer Biologics Therapy Market
  • South Korea Cancer Biologics Therapy Market
  • Rest of Asia Pacific Cancer Biologics Therapy Market
  • Latin America Cancer Biologics Therapy Market
  • Brazil Cancer Biologics Therapy Market
  • Mexico Cancer Biologics Therapy Market
  • Argentina Cancer Biologics Therapy Market
  • Rest of Latin America Cancer Biologics Therapy Market
  • Middle East & Africa Cancer Biologics Therapy Market
  • South Africa Cancer Biologics Therapy Market
  • GCC Cancer Biologics Therapy Market
  • Rest of Middle East & Africa Cancer Biologics Therapy Market

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Cancer Biologics Therapies Market and leading companies. You will find data, trends and predictions.

Buy our report today“ Cancer Biologics Therapies Market Report 2021-2031: Forecasts by Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy, Others), by Product (Monoclonal Antibodies, Cytokines, Cancer Growth Blockers, Vaccines, Blood Cell Growth Factors, and Others), by Indication (Breast Cancer, Cervical Cancer, Colon and Rectal Cancer, Gastric Cancer, Lung Cancer, Ovarian Cancer, Renal Cell Cancer, Melanoma), by Biologic Drugs (Bevacizumab, Trastuzumab, Trastuzumab Emtansine, Pertuzumab, Rituximab, Cetuximab, Panitumumab, Ramucirumab, Necitumumab, Pembrolizumab, Atezolizumab, Durvalumab, Nivolumab, Ipilimumab), by End-user (Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cancer Biologics Companies AND COVID-19 Recovery Scenarios. ” Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Cancer Biologics Therapy Market Overview
  • 1.2. Why You Should Read This Report
  • 1.3. How This Report Delivers
  • 1.4. Key Questions Answered by This Analytical Report
  • 1.5. Who Is This Report For?
  • 1.6. Methodology
    • 1.6.1. Primary Research
    • 1.6.2. Secondary Research
    • 1.6.3. Market Evaluation & Forecasting Methodology
  • 1.7. Frequently Asked Questions (FAQ)
  • 1.8. Associated Visiongain Reports
  • 1.9. About Visiongain

2. Introduction to the Cancer Biologics Therapy Market

  • 2.1. Cancer Biologics Therapy Market Definition
  • 2.2. Treatments used in Cancer Biologics Therapy Industry
    • 2.2.1. Chemotherapy
    • 2.2.2. Targeted Therapy
      • 2.2.2.1. Monoclonal Antibodies
      • 2.2.2.2. Small-Molecule Drugs
    • 2.2.3. Immunotherapy
    • 2.2.4. Hormonal Therapy
  • 2.3. Cancer Biologics Therapy Industry by Indication
    • 2.3.1. Breast Cancer
    • 2.3.2. Cervical Cancer
    • 2.3.3. Colon and Rectal Cancer
    • 2.3.4. Gastric Cancer
    • 2.3.5. Lung Cancer
    • 2.3.6. Ovarian Cancer
    • 2.3.7. Renal Cell Cancer
    • 2.3.8. Melanoma

3. Cancer Biologics Therapy Market Overview

  • 3.1. Global Oncology Spending Market Size, Market Analysis and Forecast, 2016-2031
  • 3.2. Global and Regional Cancer Biologics Therapy Market, 2016-2031
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
      • 3.3.1.1. Rising Cancer Prevalence Worldwide
      • 3.3.1.2. Increasing Ageing Population in Developed as well as Developing Economies
    • 3.3.2. Market Restraints/Challenges
      • 3.3.2.1. Shortage of Skilled Workforce in the Biopharmaceutical Industry
      • 3.3.2.2. High Cost Associated with Biopharmaceutical Drug Manufacturing
    • 3.3.3. Opportunities
      • 3.3.3.1. Increasing R&D Spending of Biopharmaceutical Companies
      • 3.3.3.2. Future Perspective in Oncology Industry
  • 3.4. Cancer Biologics Therapy Market: SWOT Analysis
  • 3.5. Cancer Biologics Therapy Market: Porter's Five Forces Model
    • 3.5.1. Bargaining Power of Buyers
    • 3.5.2. Bargaining Power of Suppliers
    • 3.5.3. Threats of New Entrants
    • 3.5.4. Threats of Substitutes
    • 3.5.5. Competitive Rivalry
  • 3.6. European Oncology Market Trends
  • 3.7. Disease Prevalence and Incidence in Europe
    • 3.7.1. Germany Cancer Incidence and Mortality
    • 3.7.2. UK Cancer Incidence and Mortality
    • 3.7.3. France Cancer Incidence and Mortality
    • 3.7.4. Italy Cancer Incidence and Mortality
    • 3.7.5. Spain Cancer Incidence and Mortality
    • 3.7.6. Portugal Cancer Incidence and Mortality
    • 3.7.7. Poland Cancer Incidence and Mortality
    • 3.7.8. Hungary Cancer Incidence and Mortality
    • 3.7.9. Czech Republic Cancer Incidence and Mortality
    • 3.7.10. Slovakia Cancer Incidence and Mortality
    • 3.7.11. Slovenia Cancer Incidence and Mortality
    • 3.7.12. Romania Cancer Incidence and Mortality
    • 3.7.13. Bulgaria Cancer Incidence and Mortality
    • 3.7.14. Croatia Cancer Incidence and Mortality
    • 3.7.15. Serbia Cancer Incidence and Mortality
    • 3.7.16. Estonia Cancer Incidence and Mortality
    • 3.7.17. Latvia Cancer Incidence and Mortality
    • 3.7.18. Lithuania Cancer Incidence and Mortality
  • 3.8. Prescription Distribution of Bevacizumab and Trastuzumab
    • 3.8.1. Prescription Distribution of Bevacizumab
      • 3.8.1.1. Metastatic Colorectal Cancer
      • 3.8.1.2. First-Line Non-Squamous Non-Small Cell Lung Cancer
      • 3.8.1.3. Recurrent Glioblastoma
      • 3.8.1.4. Metastatic Renal Cell Carcinoma
      • 3.8.1.5. Persistent, Recurrent, Or Metastatic Cervical Cancer
      • 3.8.1.6. Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
      • 3.8.1.7. Hepatocellular Carcinoma
    • 3.8.2. Prescription Distribution of Trastuzumab
      • 3.8.2.1. Adjuvant Breast Cancer
      • 3.8.2.2. Metastatic Breast Cancer
      • 3.8.2.3. Metastatic Gastric Cancer
  • 3.9. EMA Approval, Loss of Exclusivity and Introduction of Biosimilars Impact Analysis
  • 3.10. Therapeutic Schemes of Bevacizumab and Trastuzumab
  • 3.11. Patient drop-out rate
  • 3.12. Oncologist Perceptions on Biosimilars
  • 3.13. Barriers to Biologic Treatments and Expected Impact of Cheaper Options on the Market
  • 3.14. Biosimilars and R&D Biologics in Development
    • 3.14.1. Current Bevacizumab Biosimilars
    • 3.14.2. Current Trastuzumab Biosimilars
    • 3.14.3. Melanoma Indications

4. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Treatment Type

  • 4.1. Chemotherapy Market Size
    • 4.1.1. Side Effects of Chemotherapy
    • 4.1.2. Cancer Biologics Therapy Market Outlook for Chemotherapy: Recovery Scenarios (V, U, L, W)
  • 4.2. Targeted Therapy Market Size
    • 4.2.1. Examples of Targeted Therapies
    • 4.2.2. Targeted Therapies Approved for Specific Types of Cancer
    • 4.2.3. Cancer Biologics Therapy Market Outlook for Targeted Therapy: Recovery Scenarios (V, U, L, W)
    • 4.2.4. Tyrosine kinase inhibitors (small molecules) / mTOR, BRAF, etc. receptor targeted agents
    • 4.2.5. Monoclonal antibodies / mAbs (VEGF, HER, DP1, etc. receptor targeted agents)
    • 4.2.6. Antibody-drug conjugates - with mAbs or with a small molecule
  • 4.3. Immunotherapy Market Size
    • 4.3.1. What Does Immunotherapy Treat?
    • 4.3.2. Types of Immunotherapy
    • 4.3.3. Cancer Biologics Therapy Market Outlook for Immunotherapy: Recovery Scenarios (V, U, L, W)
  • 4.4. Hormonal Therapy Market Size
    • 4.4.1. Hormone Therapy for Breast Cancer
    • 4.4.2. Hormone Therapy Drugs for Breast Cancer
    • 4.4.3. Breast Cancer and Tamoxifen
    • 4.4.4. Cancer Biologics Therapy Market Outlook for Hormonal Therapy: Recovery Scenarios (V, U, L, W)
  • 4.5. Other Treatments Market Size
    • 4.5.1. Are there Vaccines that Prevent Cancer?
    • 4.5.2. Cancer Biologics Therapy Market Outlook for Other Treatments: Recovery Scenarios (V, U, L, W)

5. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Indication

  • 5.1. Breast Cancer Market Size
    • 5.1.1. Node Preservation Reduces Lymphedema Cases
    • 5.1.2. Genomic Testing Minimizes Chemotherapy Exposure
    • 5.1.3. Oral Option for Targeted Therapy
    • 5.1.4. Breast Cancer Statistics, 2020
    • 5.1.5. Cancer Biologics Therapy Market Outlook for Breast Cancer: Recovery Scenarios (V, U, L, W)
  • 5.2. Cervical Cancer Market Size
    • 5.2.1. Cancer Biologics Therapy Market Outlook for Cervical Cancer: Recovery Scenarios (V, U, L, W)
  • 5.3. Colon and Rectal Cancer Market Size
    • 5.3.1. Drugs Approved for Colon Cancer
    • 5.3.2. Drugs Combinations Used in Colon Cancer
    • 5.3.3. Drugs Approved for Rectal Cancer
    • 5.3.4. Drugs Combinations Used in Rectal Cancer
    • 5.3.5. Cancer Biologics Therapy Market Outlook for Colon and Rectal Cancer: Recovery Scenarios (V, U, L, W)
  • 5.4. Gastric Cancer Market Size
    • 5.4.1. Drugs Approved for Gastric Cancer
    • 5.4.2. Drugs Combinations Used in Gastric Cancer
    • 5.4.3. Drugs Approved for Gastroenteropancreatic Neuroendocrine Tumors
    • 5.4.4. Cancer Biologics Therapy Market Outlook for Gastric Cancer: Recovery Scenarios (V, U, L, W)
  • 5.5. Lung Cancer Market Size
    • 5.5.1. Drugs Approved for Non-Small Cell Lung Cancer
    • 5.5.2. Drug Combinations Used to Treat Non-Small Cell Lung Cancer
    • 5.5.3. Drugs Approved for Small Cell Lung Cancer
    • 5.5.4. Cancer Biologics Therapy Market Outlook for Lung Cancer: Recovery Scenarios (V, U, L, W)
  • 5.6. Ovarian Cancer Market Size
    • 5.6.1. Available Treatments for Ovarian Cancer
    • 5.6.2. What New Treatment Options are Under Development?
    • 5.6.3. Cancer Biologics Therapy Market Outlook for Ovarian Cancer: Recovery Scenarios (V, U, L, W)
  • 5.7. Renal Cell Cancer Market Size
    • 5.7.1. Cancer Biologics Therapy Market Outlook for Renal Cell Cancer: Recovery Scenarios (V, U, L, W)
  • 5.8. Melanoma Market Size
    • 5.8.1. Drugs Approved for Melanoma
    • 5.8.2. Cancer Biologics Therapy Market Outlook for Melanoma: Recovery Scenarios (V, U, L, W)
  • 5.9. Other Indications Market Size
    • 5.9.1. Cancer Biologics Therapy Market Outlook for Other Indications: Recovery Scenarios (V, U, L, W)

6. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Biologic Drugs

  • 6.1. Bevacizumab Market Size
    • 6.1.1. Bevacizumab Similar Biologic Launched in India
    • 6.1.2. Cancer Biologics Therapy Market Outlook for Bevacizumab: Recovery Scenarios (V, U, L, W)
  • 6.2. Trastuzumab Market Size
    • 6.2.1. Cancer Biologics Therapy Market Outlook for Trastuzumab: Recovery Scenarios (V, U, L, W)
  • 6.3. Trastuzumab emtansine Market Size
    • 6.3.1. Cancer Biologics Therapy Market Outlook for Trastuzumab emtansine: Recovery Scenarios (V, U, L, W)
  • 6.4. Pertuzumab Market Size
    • 6.4.1. FDA Accepted Roche's Biologics License Application
    • 6.4.2. Cancer Biologics Therapy Market Outlook for Pertuzumab: Recovery Scenarios (V, U, L, W)
  • 6.5. Rituximab Market Size
    • 6.5.1. Cancer Biologics Therapy Market Outlook for Rituximab: Recovery Scenarios (V, U, L, W)
  • 6.6. Cetuximab Market Size
    • 6.6.1. Cancer Biologics Therapy Market Outlook for Cetuximab: Recovery Scenarios (V, U, L, W)
  • 6.7. Panitumumab Market Size
    • 6.7.1. Cancer Biologics Therapy Market Outlook for Panitumumab: Recovery Scenarios (V, U, L, W)
  • 6.8. Ramucirumab Market Size
    • 6.8.1. Cancer Biologics Therapy Market Outlook for Ramucirumab: Recovery Scenarios (V, U, L, W)
  • 6.9. Necitumumab Market Size
    • 6.9.1. Role of Necitumumab in the Treatment of Non-Small Cell Lung Cancer (NSCLC)?
    • 6.9.2. Cancer Biologics Therapy Market Outlook for Necitumumab: Recovery Scenarios (V, U, L, W)
  • 6.10. Pembrolizumab Market Size
    • 6.10.1. What Pembrolizumab Is Used For:
    • 6.10.2. Cancer Biologics Therapy Market Outlook for Pembrolizumab: Recovery Scenarios (V, U, L, W)
  • 6.11. Atezolizumab Market Size
    • 6.11.1. Atezolizumab Drug Used in below Indications
    • 6.11.2. Cancer Biologics Therapy Market Outlook for Atezolizumab: Recovery Scenarios (V, U, L, W)
  • 6.12. Durvalumab Market Size
    • 6.12.1. FDA Approved Durvalumab for Extensive-Stage Small Cell Lung Cancer
    • 6.12.2. Cancer Biologics Therapy Market Outlook for Durvalumab: Recovery Scenarios (V, U, L, W)
  • 6.13. Nivolumab Market Size
    • 6.13.1. FDA to Review Additional GI Cancer Indications for Nivolumab
    • 6.13.2. Cancer Biologics Therapy Market Outlook for Nivolumab: Recovery Scenarios (V, U, L, W)
  • 6.14. Ipilimumab Market Size
    • 6.14.1. Cancer Biologics Therapy Market Outlook for Ipilimumab: Recovery Scenarios (V, U, L, W)

7. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by Product

  • 7.1. Monoclonal Antibodies Market Size
    • 7.1.1. Cancer Biologics Therapy Market Outlook for Monoclonal Antibodies: Recovery Scenarios (V, U, L, W)
  • 7.2. Cytokines Market Size
    • 7.2.1. Cancer Biologics Therapy Market Outlook for Cytokines: Recovery Scenarios (V, U, L, W)
  • 7.3. Cancer Growth Blockers Market Size
    • 7.3.1. Types of Cancer Growth Blockers
    • 7.3.2. Possible Side Effects of Cancer Growth Blockers
    • 7.3.3. Cancer Biologics Therapy Market Outlook for Cancer Growth Blockers: Recovery Scenarios (V, U, L, W)
  • 7.4. Vaccines Market Size
    • 7.4.1. Cancer Biologics Therapy Market Outlook for Vaccines: Recovery Scenarios (V, U, L, W)
  • 7.5. Blood Cell Growth Factors Market Size
    • 7.5.1. Cancer Biologics Therapy Market Outlook for Blood Cell Growth Factors: Recovery Scenarios (V, U, L, W)
  • 7.6. Others Market Size
    • 7.6.1. Cancer Biologics Therapy Market Outlook for Others: Recovery Scenarios (V, U, L, W)

8. Global Cancer Biologics Therapy Market Analysis and Forecast 2021-2031, by End User

  • 8.1. Hospitals Market Size
    • 8.1.1. Cancer Biologics Therapy Market Outlook for Hospitals: Recovery Scenarios (V, U, L, W)
  • 8.2. Specialty Clinics Market Size
    • 8.2.1. Cancer Biologics Therapy Market Outlook for Specialty Clinics: Recovery Scenarios (V, U, L, W)
  • 8.3. Cancer and Radiation Therapy Centers Market Size
    • 8.3.1. How is the Cancer Research Institute Involved in the Development of Immunotherapy?
    • 8.3.2. Cancer Biologics Therapy Market Outlook for Cancer and Radiation Therapy Centers: Recovery Scenarios (V, U, L, W)

9. North America Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031

  • 9.1. North America Cancer Biologics Therapy Market Size
    • 9.1.1. North America Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
  • 9.2. U.S. Cancer Biologics Therapy Market Size
  • 9.3. Canada Cancer Biologics Therapy Market Size

10. Europe Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031

  • 10.1. Europe Cancer Biologics Therapy Market Size
    • 10.1.1. Europe Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
  • 10.2. UK Cancer Biologics Therapy Market Size
  • 10.3. Germany Cancer Biologics Therapy Market Size
  • 10.4. France Cancer Biologics Therapy Market Size
  • 10.5. Italy Cancer Biologics Therapy Market Size
  • 10.6. Spain Cancer Biologics Therapy Market Size
  • 10.7. Portugal Cancer Biologics Therapy Market Size
  • 10.8. Poland Cancer Biologics Therapy Market Size
  • 10.9. Hungary Cancer Biologics Therapy Market Size
  • 10.10. Czech Republic Cancer Biologics Therapy Market Size
  • 10.11. Slovakia Cancer Biologics Therapy Market Size
  • 10.12. Slovenia Cancer Biologics Therapy Market Size
  • 10.13. Romania Cancer Biologics Therapy Market Size
  • 10.14. Bulgaria Cancer Biologics Therapy Market Size
  • 10.15. Croatia Cancer Biologics Therapy Market Size
  • 10.16. Baltic States Cancer Biologics Therapy Market Size
  • 10.17. Serbia Cancer Biologics Therapy Market Size
  • 10.18. Rest of Europe Cancer Biologics Therapy Market Size

11. Asia Pacific Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031

  • 11.1. Asia Pacific Cancer Biologics Therapy Market Size
    • 11.1.1. Asia Pacific Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
  • 11.2. China Cancer Biologics Therapy Market Size
  • 11.3. India Cancer Biologics Therapy Market Size
  • 11.4. Japan Cancer Biologics Therapy Market Size
  • 11.5. South Korea Cancer Biologics Therapy Market Size
  • 11.6. Australia Cancer Biologics Therapy Market Size
  • 11.7. Rest of Asia Pacific Cancer Biologics Therapy Market Size

12. Latin America Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031

  • 12.1. Latin America Cancer Biologics Therapy Market Size
    • 12.1.1. Latin America Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
  • 12.2. Brazil Cancer Biologics Therapy Market Size
  • 12.3. Mexico Cancer Biologics Therapy Market Size
  • 12.4. Argentina Cancer Biologics Therapy Market Size
  • 12.5. Rest of Latin America Cancer Biologics Therapy Market Size

13. Middle East & Africa Cancer Biologics Therapy Market Analysis and Forecast, 2021-2031

  • 13.1. Middle East & Africa Cancer Biologics Therapy Market Size
    • 13.1.1. Middle East & Africa Cancer Biologics Therapy Market Outlook: Recovery Scenarios (V, U, L, W)
  • 13.2. South Africa Cancer Biologics Therapy Market Size
  • 13.3. GCC Cancer Biologics Therapy Market Size
  • 13.4. Rest of Middle East & Africa Cancer Biologics Therapy Market Size

14. Company Profiles

  • 14.1. AbbVie Inc.
    • 14.1.1. AbbVie Inc. Snapshot
    • 14.1.2. Company Overview
    • 14.1.3. Product Offerings
    • 14.1.4. AbbVie Inc.: Recent Initiatives, 2017 - 2020
    • 14.1.5. Financial Performance (2015 - 2019)
      • 14.1.5.1. Net Revenue (2015 - 2019)
      • 14.1.5.2. Gross Profit (2015 - 2019)
      • 14.1.5.3. Geographical Revenue, 2019
  • 14.2. F.Hoffman La Roche
    • 14.2.1. F.Hoffman La Roche Snapshot
    • 14.2.2. Company Overview
    • 14.2.3. Product Offerings
    • 14.2.4. F.Hoffman La Roche: Recent Initiatives, 2017 - 2020
    • 14.2.5. Financial Performance (2015 - 2019)
      • 14.2.5.1. Net Revenue (2015 - 2019)
      • 14.2.5.2. Gross Profit (2015 - 2019)
      • 14.2.5.3. Geographical Revenue, 2019
  • 14.3. GlaxoSmithKline
    • 14.3.1. GlaxoSmithKline Snapshot
    • 14.3.2. Company Overview
    • 14.3.3. Product Offerings
    • 14.3.4. GlaxoSmithKline: Recent Initiatives, 2017 - 2020
    • 14.3.5. Financial Performance (2015 - 2019)
      • 14.3.5.1. Net Revenue (2015 - 2019)
      • 14.3.5.2. Gross Profit (2015 - 2019)
      • 14.3.5.3. Geographical Revenue, 2019
  • 14.4. Eli Lilly and Company
    • 14.4.1. Eli Lilly and Company Snapshot
    • 14.4.2. Company Overview
    • 14.4.3. Product Offerings
    • 14.4.4. Eli Lilly and Company: Recent Initiatives, 2017 - 2020
    • 14.4.5. Financial Performance (2015 - 2019)
      • 14.4.5.1. Net Revenue (2015 - 2019)
      • 14.4.5.2. Gross Profit (2015 - 2019)
      • 14.4.5.3. Geographical Revenue, 2019
  • 14.5. Amgen
    • 14.5.1. Amgen Snapshot
    • 14.5.2. Company Overview
    • 14.5.3. Product Offerings
    • 14.5.4. Amgen: Recent Initiatives, 2017 - 2020
    • 14.5.5. Financial Performance (2015 - 2019)
      • 14.5.5.1. Net Revenue (2015 - 2019)
      • 14.5.5.2. Gross Profit (2015 - 2019)
      • 14.5.5.3. Geographical Revenue, 2019
  • 14.6. Johnson & Johnson
    • 14.6.1. Johnson & Johnson Snapshot
    • 14.6.2. Company Overview
    • 14.6.3. Product Offerings
    • 14.6.4. Johnson & Johnson: Recent Initiatives, 2017 - 2020
    • 14.6.5. Financial Performance (2015 - 2019)
      • 14.6.5.1. Net Revenue (2015 - 2019)
      • 14.6.5.2. Gross Profit (2015 - 2019)
      • 14.6.5.3. Geographical Revenue, 2019
  • 14.7. Merck & Co.
    • 14.7.1. Merck & Co. Snapshot
    • 14.7.2. Company Overview
    • 14.7.3. Product Offerings
    • 14.7.4. Merck & Co.: Recent Initiatives, 2017 - 2020
    • 14.7.5. Financial Performance (2015 - 2019)
      • 14.7.5.1. Net Revenue (2015 - 2019)
      • 14.7.5.2. Gross Profit (2015 - 2019)
      • 14.7.5.3. Geographical Revenue, 2019
  • 14.8. Pfizer
    • 14.8.1. Pfizer Snapshot
    • 14.8.2. Company Overview
    • 14.8.3. Product Offerings
    • 14.8.4. Pfizer: Recent Initiatives, 2017 - 2020
    • 14.8.5. Financial Performance (2015 - 2019)
      • 14.8.5.1. Net Revenue (2015 - 2019)
      • 14.8.5.2. Gross Profit (2015 - 2019)
      • 14.8.5.3. Geographical Revenue, 2019
  • 14.9. Agilent Technologies, Inc.
    • 14.9.1. Company Overview
    • 14.9.2. Product Benchmarking
    • 14.9.3. Agilent Technologies, Inc.: Recent Initiatives
    • 14.9.4. Financial Performance (2016 - 2019)
  • 14.10. Bio-Rad Laboratories
    • 14.10.1. Company Overview
    • 14.10.2. Product Benchmarking
    • 14.10.3. Bio-Rad Laboratories: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
    • 14.10.4. Financials
  • 14.11. GE Healthcare
    • 14.11.1. Company Overview
    • 14.11.2. Product Benchmarking
    • 14.11.3. GE Healthcare: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
    • 14.11.4. Financials
  • 14.12. Illumina
    • 14.12.1. Company Overview
    • 14.12.2. Product Benchmarking
    • 14.12.3. Illumina: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
    • 14.12.4. Financials
  • 14.13. Qiagen N.V.
    • 14.13.1. Company Overview
    • 14.13.2. Product Benchmarking
    • 14.13.3. Qiagen N.V.: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
    • 14.13.4. Financials
  • 14.14. Biocept
    • 14.14.1. Biocept Snapshot
    • 14.14.2. Company Overview
    • 14.14.3. Product Offerings
    • 14.14.4. Biocept: Recent Initiatives, 2017 - 2020
    • 14.14.5. Financial Performance (2015 - 2019)
  • 14.15. Guardant Health
    • 14.15.1. Guardant Health Snapshot
    • 14.15.2. Company Overview
    • 14.15.3. Product Offerings
    • 14.15.4. Guardant Health: Recent Initiatives, 2017 - 2020
    • 14.15.5. Financial Performance (2015 - 2019)

15. Conclusion

  • 15.1. Concluding Remarks
  • 15.2. Recommendations

List of Figures

  • Figure 1 Cancer Biologics Therapy: Market Segmentation and Scope
  • Figure 2 Global Oncology Spending Market Value Forecast, 2016 - 2031 (USD Billion)
  • Figure 3 Global Oncology Spending Market Share by Region, 2020 (%)
  • Figure 4 Cancer Biologics Therapy Market Share by Region, 2021, 2026, 2031 (%)
  • Figure 5 Worldwide Cancer Death by Age, 2019 (%)
  • Figure 6 Share of population with Cancer, 2019 (%)
  • Figure 7 Ageing Population Estimates 2010 - 2050
  • Figure 8 Research & Development Spending as a Percent of Revenue by Biopharmaceutical Companies, 2019 (%)
  • Figure 9 Cancer Biologics Therapy Industry: Porter's Five Forces Model
  • Figure 10 Germany: Estimated Incidence by Cancer, 2020 (%)
  • Figure 11 Germany: Estimated Mortality by Cancer, 2020 (%)
  • Figure 12 UK: Estimated Incidence by Cancer, 2020 (%)
  • Figure 13 UK: Estimated Mortality by Cancer, 2020 (%)
  • Figure 14 France: Estimated Incidence by Cancer, 2020 (%)
  • Figure 15 France: Estimated Mortality by Cancer, 2020 (%)
  • Figure 16 Italy: Estimated Incidence by Cancer, 2020 (%)
  • Figure 17 Italy: Estimated Mortality by Cancer, 2020 (%)
  • Figure 18 Spain: Estimated Incidence by Cancer, 2020 (%)
  • Figure 19 Spain: Estimated Mortality by Cancer, 2020 (%)
  • Figure 20 Portugal: Estimated Incidence by Cancer, 2020 (%)
  • Figure 21 Portugal: Estimated Mortality by Cancer, 2020 (%)
  • Figure 22 Poland: Estimated Incidence by Cancer, 2020 (%)
  • Figure 23 Poland: Estimated Mortality by Cancer, 2020 (%)
  • Figure 24 Hungary: Estimated Incidence by Cancer, 2020 (%)
  • Figure 25 Hungary: Estimated Mortality by Cancer, 2020 (%)
  • Figure 26 Czech Republic: Estimated Incidence by Cancer, 2020 (%)
  • Figure 27 Czech Republic: Estimated Mortality by Cancer, 2020 (%)
  • Figure 28 Slovakia: Estimated Incidence by Cancer, 2020 (%)
  • Figure 29 Slovakia: Estimated Mortality by Cancer, 2020 (%)
  • Figure 30 Slovenia: Estimated Incidence by Cancer, 2020 (%)
  • Figure 31 Slovenia: Estimated Mortality by Cancer, 2020 (%)
  • Figure 32 Romania: Estimated Incidence by Cancer, 2020 (%)
  • Figure 33 Romania: Estimated Mortality by Cancer, 2020 (%)
  • Figure 34 Bulgaria: Estimated Incidence by Cancer, 2020 (%)
  • Figure 35 Bulgaria: Estimated Mortality by Cancer, 2020 (%)
  • Figure 36 Croatia: Estimated Incidence by Cancer, 2020 (%)
  • Figure 37 Croatia: Estimated Mortality by Cancer, 2020 (%)
  • Figure 38 Serbia: Estimated Incidence by Cancer, 2020 (%)
  • Figure 39 Serbia: Estimated Mortality by Cancer, 2020 (%)
  • Figure 40 Estonia: Estimated Incidence by Cancer, 2020 (%)
  • Figure 41 Estonia: Estimated Mortality by Cancer, 2020 (%)
  • Figure 42 Latvia: Estimated Incidence by Cancer, 2020 (%)
  • Figure 43 Latvia: Estimated Mortality by Cancer, 2020 (%)
  • Figure 44 Lithuania: Estimated Incidence by Cancer, 2020 (%)
  • Figure 45 Lithuania: Estimated Mortality by Cancer, 2020 (%)
  • Figure 46 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 47 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 48 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 49 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 50 Cancer Biologics Therapy for Chemotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 51 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 52 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 53 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 54 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 55 Cancer Biologics Therapy for Targeted Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 56 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 57 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 58 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 59 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 60 Cancer Biologics Therapy for Immunotherapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 61 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 62 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 63 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 64 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 65 Cancer Biologics Therapy for Hormonal Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 66 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 67 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 68 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 69 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 70 Cancer Biologics Therapy for Other Treatments Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 71 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 72 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 73 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 74 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 75 Cancer Biologics Therapy for Breast Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 76 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 77 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 78 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 79 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 80 Cancer Biologics Therapy for Cervical Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 81 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 82 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 83 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 84 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 85 Cancer Biologics Therapy for Colon and Rectal Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 86 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 87 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 88 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 89 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 90 Cancer Biologics Therapy for Gastric Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 91 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 92 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 93 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 94 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 95 Cancer Biologics Therapy for Lung Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 96 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 97 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 98 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 99 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 100 Cancer Biologics Therapy for Ovarian Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 101 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 102 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 103 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 104 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 105 Cancer Biologics Therapy for Renal Cell Cancer Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 106 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 107 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 108 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 109 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 110 Cancer Biologics Therapy for Melanoma Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 111 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 112 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 113 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 114 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 115 Cancer Biologics Therapy for Other Indications Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 116 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 117 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 118 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 119 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 120 Cancer Biologics Therapy for Bevacizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 121 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 122 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 123 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 124 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 125 Cancer Biologics Therapy for Trastuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 126 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 127 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 128 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 129 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 130 Cancer Biologics Therapy for Trastuzumab emtansine Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 131 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 132 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 133 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 134 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 135 Cancer Biologics Therapy for Pertuzumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 136 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 137 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 138 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 139 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 140 Cancer Biologics Therapy for Rituximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 141 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 142 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 143 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 144 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 145 Cancer Biologics Therapy for Cetuximab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 146 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 147 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 148 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 149 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 150 Cancer Biologics Therapy for Panitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 151 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 152 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 153 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 154 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 155 Cancer Biologics Therapy for Ramucirumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 156 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 157 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 158 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 159 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 160 Cancer Biologics Therapy for Necitumumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 161 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 162 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 163 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 164 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 165 Cancer Biologics Therapy for Pembrolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 166 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 167 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 168 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 169 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 170 Cancer Biologics Therapy for Atezolizumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 171 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 172 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 173 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 174 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 175 Cancer Biologics Therapy for Durvalumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 176 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 177 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 178 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 179 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 180 Cancer Biologics Therapy for Nivolumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 181 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 182 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 183 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 184 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 185 Cancer Biologics Therapy for Ipilimumab Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 186 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 187 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 188 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 189 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 190 Cancer Biologics Therapy for Monoclonal Antibodies Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 191 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 192 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 193 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 194 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 195 Cancer Biologics Therapy for Cytokines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 196 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 197 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 198 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 199 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 200 Cancer Biologics Therapy for Cancer Growth Blockers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 201 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 202 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 203 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 204 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 205 Cancer Biologics Therapy for Vaccines Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 206 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 207 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 208 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 209 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 210 Cancer Biologics Therapy for Blood Cell Growth Factors Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 211 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 212 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 213 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 214 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 215 Cancer Biologics Therapy for Others Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 216 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 217 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 218 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 219 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 220 Cancer Biologics Therapy for Hospitals Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 221 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 222 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 223 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 224 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 225 Cancer Biologics Therapy for Specialty Clinics Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 226 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 227 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 228 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 229 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 230 Cancer Biologics Therapy for Cancer and Radiation Therapy Centers Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 231 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 232 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 233 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 234 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 235 North America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 236 U.S. Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 237 Canada Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 238 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 239 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 240 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 241 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 242 Europe Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 243 UK Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 244 Germany Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 245 France Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 246 Italy Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 247 Spain Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 248 Portugal Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 249 Poland Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 250 Hungary Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 251 Czech Republic Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 252 Slovakia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 253 Slovenia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 254 Romania Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 255 Bulgaria Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 256 Croatia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 257 Baltic States Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 258 Serbia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 259 Serbia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 260 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 261 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 262 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 263 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 264 Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 265 China Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 266 India Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 267 Japan Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 268 South Korea Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 269 Australia Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 270 Rest of Asia Pacific Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 271 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 272 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 273 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 274 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 275 Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 276 Brazil Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 277 Mexico Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 278 Argentina Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 279 Rest of Latin America Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 280 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 281 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): V Shaped Recovery
  • Figure 282 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): U Shaped Recovery
  • Figure 283 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): L Shaped Recovery
  • Figure 284 Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %): W Shaped Recovery
  • Figure 285 South Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 286 GCC Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 287 Rest of Middle East & Africa Cancer Biologics Therapy Market Value Forecast, 2021 - 2031 (USD Billion, AGR %)
  • Figure 288 AbbVie Inc.: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 289 AbbVie Inc.: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 290 AbbVie Inc.: Geographical Revenue, 2019 (USD Million)
  • Figure 291 F.Hoffman La Roche: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 292 F.Hoffman La Roche: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 293 F.Hoffman La Roche: Geographical Revenue, 2019 (USD Million)
  • Figure 294 GlaxoSmithKline: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 295 GlaxoSmithKline: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 296 GlaxoSmithKline: Geographical Revenue, 2019 (USD Million)
  • Figure 297 Eli Lilly and Company: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 298 Eli Lilly and Company: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 299 Eli Lilly and Company: Geographical Revenue, 2019 (USD Million)
  • Figure 300 Amgen: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 301 Amgen: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 302 Amgen: Geographical Revenue, 2019 (USD Million)
  • Figure 303 Johnson & Johnson: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 304 Johnson & Johnson: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 305 Johnson & Johnson: Geographical Revenue, 2019 (USD Million)
  • Figure 306 Merck & Co.: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 307 Merck & Co.: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 308 Merck & Co.: Geographical Revenue, 2019 (USD Million)
  • Figure 309 Pfizer: Net Revenue 2015 - 2019, (USD Million, AGR %)
  • Figure 310 Pfizer: Gross Profit 2015 - 2019, (USD Million, AGR %)
  • Figure 311 Pfizer: Geographical Revenue, 2019 (USD Million)
  • Figure 312 Agilent Technologies, Inc.: Financials 2016 - 2019, (USD Million, AGR %)
  • Figure 313 Agilent Technologies, Inc.: Business Segment, 2019 (%)
  • Figure 314 Agilent Technologies, Inc.: Sales by Type, 2019 (%)
  • Figure 315 Agilent Technologies, Inc.: Market by Region, 2019 (%)
  • Figure 316 Bio-Rad Laboratories: Financials 2016 - 2019, (USD Million, AGR %)
  • Figure 317 Bio-Rad Laboratories: Business Segment, 2019 (%)
  • Figure 318 Bio-Rad Laboratories: Market by Region, 2019 (%)
  • Figure 319 GE Healthcare: Financials 2016 - 2019, (USD Million, AGR %)
  • Figure 320 GE Healthcare: Business Segment, 2019 (%)
  • Figure 321 GE Healthcare: Type of Sales, 2019 (%)
  • Figure 322 GE Healthcare: Market by Region, 2019 (%)
  • Figure 323 Illumina: Financials 2016 - 2019, (USD Million, AGR %)
  • Figure 324 Illumina: Business Segment, 2019 (%)
  • Figure 325 Illumina: Market by Region, 2019 (%)
  • Figure 326 Qiagen N.V.: Financials 2016 - 2019, (USD Million, AGR %)
  • Figure 327 Qiagen N.V.: Business Segment, 2019 (%)
  • Figure 328 Qiagen N.V.: Market by Region, 2019 (%)
  • Figure 329 Biocept: Net Revenue 2015 - 2019, (USD Thousand, AGR %)
  • Figure 330 Guardant Health: Net Revenue 2015 - 2019, (USD Million, AGR %)

List of Tables

  • Table 1 Cancer Biologics Therapy Market, 2016-2020 (USD Billion)
  • Table 2 Cancer Biologics Therapy Market, 2021-2031 (USD Billion)
  • Table 3 Cancer Biologics Therapy Market: SWOT Analysis
  • Table 4 EMA Approved Biosimilars in Oncology
  • Table 5 FDA Approved Biosimilars in Oncology
  • Table 6 Current Bevacizumab Biosimilars
  • Table 7 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 8 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 9 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 10 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 11 Cancer Biologics Therapy Market for Chemotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 12 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 13 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 14 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 15 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 16 Cancer Biologics Therapy Market for Targeted Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 17 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 18 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 19 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 20 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 21 Cancer Biologics Therapy Market for Immunotherapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 22 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 23 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 24 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 25 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 26 Cancer Biologics Therapy Market for Hormonal Therapy, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 27 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 28 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 29 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 30 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 31 Cancer Biologics Therapy Market for Other Treatments, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 32 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 33 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 34 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 35 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 36 Cancer Biologics Therapy Market for Breast Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 37 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 38 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 39 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 40 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 41 Cancer Biologics Therapy Market for Cervical Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 42 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 43 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 44 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 45 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 46 Cancer Biologics Therapy Market for Colon and Rectal Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 47 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 48 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 49 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 50 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 51 Cancer Biologics Therapy Market for Gastric Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 52 Cancer Biologics Therapy Market for Lung Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 53 Cancer Biologics Therapy Market for Lung Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 54 Cancer Biologics Therapy Market for Lung Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 55 Cancer Biologics Therapy Market for Lung Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 56 Cancer Biologics Therapy Market for Lung Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 57 Cancer Biologics Therapy Market for Ovarian Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 58 Cancer Biologics Therapy Market for Ovarian Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 59 Cancer Biologics Therapy Market for Ovarian Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 60 Cancer Biologics Therapy Market for Ovarian Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 61 Cancer Biologics Therapy Market for Ovarian Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 62 Cancer Biologics Therapy Market for Renal Cell Cancer, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 63 Cancer Biologics Therapy Market for Renal Cell Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 64 Cancer Biologics Therapy Market for Renal Cell Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 65 Cancer Biologics Therapy Market for Renal Cell Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 66 Cancer Biologics Therapy Market for Renal Cell Cancer, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 67 Cancer Biologics Therapy Market for Melanoma, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 68 Cancer Biologics Therapy Market for Melanoma, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 69 Cancer Biologics Therapy Market for Melanoma, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 70 Cancer Biologics Therapy Market for Melanoma, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 71 Cancer Biologics Therapy Market for Melanoma, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 72 Cancer Biologics Therapy Market for Other Indications, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 73 Cancer Biologics Therapy Market for Other Indications, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 74 Cancer Biologics Therapy Market for Other Indications, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 75 Cancer Biologics Therapy Market for Other Indications, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 76 Cancer Biologics Therapy Market for Other Indications, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 77 Cancer Biologics Therapy Market for Bevacizumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 78 Cancer Biologics Therapy Market for Bevacizumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 79 Cancer Biologics Therapy Market for Bevacizumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 80 Cancer Biologics Therapy Market for Bevacizumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 81 Cancer Biologics Therapy Market for Bevacizumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 82 Cancer Biologics Therapy Market for Trastuzumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 83 Cancer Biologics Therapy Market for Trastuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 84 Cancer Biologics Therapy Market for Trastuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 85 Cancer Biologics Therapy Market for Trastuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 86 Cancer Biologics Therapy Market for Trastuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 87 Cancer Biologics Therapy Market for Trastuzumab emtansine, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 88 Cancer Biologics Therapy Market for Trastuzumab emtansine, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 89 Cancer Biologics Therapy Market for Trastuzumab emtansine, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 90 Cancer Biologics Therapy Market for Trastuzumab emtansine, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 91 Cancer Biologics Therapy Market for Trastuzumab emtansine, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 92 Cancer Biologics Therapy Market for Pertuzumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 93 Cancer Biologics Therapy Market for Pertuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 94 Cancer Biologics Therapy Market for Pertuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 95 Cancer Biologics Therapy Market for Pertuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 96 Cancer Biologics Therapy Market for Pertuzumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 97 Cancer Biologics Therapy Market for Rituximab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 98 Cancer Biologics Therapy Market for Rituximab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 99 Cancer Biologics Therapy Market for Rituximab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 100 Cancer Biologics Therapy Market for Rituximab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 101 Cancer Biologics Therapy Market for Rituximab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 102 Cancer Biologics Therapy Market for Cetuximab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 103 Cancer Biologics Therapy Market for Cetuximab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 104 Cancer Biologics Therapy Market for Cetuximab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 105 Cancer Biologics Therapy Market for Cetuximab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 106 Cancer Biologics Therapy Market for Cetuximab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 107 Cancer Biologics Therapy Market for Panitumumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 108 Cancer Biologics Therapy Market for Panitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 109 Cancer Biologics Therapy Market for Panitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 110 Cancer Biologics Therapy Market for Panitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 111 Cancer Biologics Therapy Market for Panitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 112 Cancer Biologics Therapy Market for Ramucirumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 113 Cancer Biologics Therapy Market for Ramucirumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 114 Cancer Biologics Therapy Market for Ramucirumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 115 Cancer Biologics Therapy Market for Ramucirumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 116 Cancer Biologics Therapy Market for Ramucirumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 117 Cancer Biologics Therapy Market for Necitumumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 118 Cancer Biologics Therapy Market for Necitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 119 Cancer Biologics Therapy Market for Necitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 120 Cancer Biologics Therapy Market for Necitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 121 Cancer Biologics Therapy Market for Necitumumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 122 Cancer Biologics Therapy Market for Pembrolizumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 123 Cancer Biologics Therapy Market for Pembrolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 124 Cancer Biologics Therapy Market for Pembrolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 125 Cancer Biologics Therapy Market for Pembrolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 126 Cancer Biologics Therapy Market for Pembrolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 127 Cancer Biologics Therapy Market for Atezolizumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 128 Cancer Biologics Therapy Market for Atezolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 129 Cancer Biologics Therapy Market for Atezolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 130 Cancer Biologics Therapy Market for Atezolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 131 Cancer Biologics Therapy Market for Atezolizumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 132 Cancer Biologics Therapy Market for Durvalumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 133 Cancer Biologics Therapy Market for Durvalumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 134 Cancer Biologics Therapy Market for Durvalumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 135 Cancer Biologics Therapy Market for Durvalumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 136 Cancer Biologics Therapy Market for Durvalumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 137 Cancer Biologics Therapy Market for Nivolumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 138 Cancer Biologics Therapy Market for Nivolumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 139 Cancer Biologics Therapy Market for Nivolumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 140 Cancer Biologics Therapy Market for Nivolumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 141 Cancer Biologics Therapy Market for Nivolumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 142 Cancer Biologics Therapy Market for Ipilimumab, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 143 Cancer Biologics Therapy Market for Ipilimumab, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 144 Cancer Biologics Therapy Market for Ipilimumab, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 145 Cancer Biologics Therapy Market for Ipilimumab, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 146 Cancer Biologics Therapy Market for Ipilimumab, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 147 US FDA-Approved Monoclonal Antibody on the Market
  • Table 148 Cancer Biologics Therapy Market for Monoclonal Antibodies, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 149 Cancer Biologics Therapy Market for Monoclonal Antibodies, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 150 Cancer Biologics Therapy Market for Monoclonal Antibodies, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 151 Cancer Biologics Therapy Market for Monoclonal Antibodies, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 152 Cancer Biologics Therapy Market for Monoclonal Antibodies, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 153 Cytokines in Cancer Pathogenesis
  • Table 154 Cancer Biologics Therapy Market for Cytokines, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 155 Cancer Biologics Therapy Market for Cytokines, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 156 Cancer Biologics Therapy Market for Cytokines, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 157 Cancer Biologics Therapy Market for Cytokines, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 158 Cancer Biologics Therapy Market for Cytokines, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 159 Cancer Biologics Therapy Market for Cancer Growth Blockers, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 160 Cancer Biologics Therapy Market for Cancer Growth Blockers, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 161 Cancer Biologics Therapy Market for Cancer Growth Blockers, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 162 Cancer Biologics Therapy Market for Cancer Growth Blockers, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 163 Cancer Biologics Therapy Market for Cancer Growth Blockers, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 164 Cancer Biologics Therapy Market for Vaccines, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 165 Cancer Biologics Therapy Market for Vaccines, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 166 Cancer Biologics Therapy Market for Vaccines, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 167 Cancer Biologics Therapy Market for Vaccines, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 168 Cancer Biologics Therapy Market for Vaccines, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 169 Cancer Biologics Therapy Market for Blood Cell Growth Factors, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 170 Cancer Biologics Therapy Market for Blood Cell Growth Factors, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 171 Cancer Biologics Therapy Market for Blood Cell Growth Factors, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 172 Cancer Biologics Therapy Market for Blood Cell Growth Factors, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 173 Cancer Biologics Therapy Market for Blood Cell Growth Factors, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 174 Cancer Biologics Therapy Market for Others, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 175 Cancer Biologics Therapy Market for Others, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 176 Cancer Biologics Therapy Market for Others, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 177 Cancer Biologics Therapy Market for Others, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 178 Cancer Biologics Therapy Market for Others, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 179 Cancer Biologics Therapy Market for Hospitals, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 180 Cancer Biologics Therapy Market for Hospitals, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 181 Cancer Biologics Therapy Market for Hospitals, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 182 Cancer Biologics Therapy Market for Hospitals, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 183 Cancer Biologics Therapy Market for Hospitals, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 184 Cancer Biologics Therapy Market for Specialty Clinics, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 185 Cancer Biologics Therapy Market for Specialty Clinics, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 186 Cancer Biologics Therapy Market for Specialty Clinics, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 187 Cancer Biologics Therapy Market for Specialty Clinics, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 188 Cancer Biologics Therapy Market for Specialty Clinics, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 189 Cancer Biologics Therapy Market for Cancer and Radiation Therapy Centers, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 190 Cancer Biologics Therapy Market for Cancer and Radiation Therapy Centers, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 191 Cancer Biologics Therapy Market for Cancer and Radiation Therapy Centers, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 192 Cancer Biologics Therapy Market for Cancer and Radiation Therapy Centers, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 193 Cancer Biologics Therapy Market for Cancer and Radiation Therapy Centers, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 194 North America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 195 North America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 196 North America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 197 North America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 198 North America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 199 U.S. Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 200 Canada Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 201 Europe Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 202 Europe Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 203 Europe Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 204 Europe Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 205 Europe Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 206 UK Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 207 Germany Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 208 France Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 209 Italy Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 210 Spain Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 211 Portugal Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 212 Poland Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 213 Hungary Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 214 Czech Republic Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 215 Slovakia Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 216 Slovenia Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 217 Romania Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 218 Bulgaria Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 219 Croatia Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 220 Baltic States Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 221 Serbia Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 222 Serbia Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 223 Asia Pacific Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 224 Asia Pacific Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 225 Asia Pacific Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 226 Asia Pacific Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 227 Asia Pacific Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 228 China Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 229 India Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 230 Japan Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 231 South Korea Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 232 Australia Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 233 Rest of Asia Pacific Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 234 Latin America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 235 Latin America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 236 Latin America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 237 Latin America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 238 Latin America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 239 Brazil Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 240 Mexico Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 241 Argentina Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 242 Rest of Latin America Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 243 Middle East & Africa Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 244 Middle East & Africa Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): V Shaped Recovery
  • Table 245 Middle East & Africa Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): U Shaped Recovery
  • Table 246 Middle East & Africa Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): L Shaped Recovery
  • Table 247 Middle East & Africa Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %): W Shaped Recovery
  • Table 248 South Africa Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 249 GCC Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 250 Rest of Middle East & Africa Cancer Biologics Therapy Market, 2021-2031 (USD Billion, AGR %, CAGR %)
  • Table 251 AbbVie Inc.: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 252 AbbVie Inc.: Product Offerings
  • Table 253 AbbVie Inc.: Recent Initiatives, 2017 - 2020
  • Table 254 F.Hoffman La Roche: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 255 F.Hoffman La Roche: Product Offerings
  • Table 256 F.Hoffman La Roche: Recent Initiatives, 2017 - 2020
  • Table 257 GlaxoSmithKline: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 258 GlaxoSmithKline: Product Offerings
  • Table 259 GlaxoSmithKline: Recent Initiatives, 2017 - 2020
  • Table 260 Eli Lilly and Company: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 261 Eli Lilly and Company: Product Offerings
  • Table 262 Eli Lilly and Company: Recent Initiatives, 2017 - 2020
  • Table 263 Amgen: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 264 Amgen: Product Offerings
  • Table 265 Amgen: Recent Initiatives, 2017 - 2020
  • Table 266 Johnson & Johnson: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 267 Johnson & Johnson: Product Offerings
  • Table 268 Johnson & Johnson: Recent Initiatives, 2017 - 2020
  • Table 269 Merck & Co.: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 270 Merck & Co.: Product Offerings
  • Table 271 Merck & Co.: Recent Initiatives, 2017 - 2020
  • Table 272 Pfizer: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 273 Pfizer: Product Offerings
  • Table 274 Pfizer: Recent Initiatives, 2017 - 2020
  • Table 275 Agilent Technologies, Inc.: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 276 Agilent Technologies, Inc.: Product Portfolio
  • Table 277 Agilent Technologies, Inc.: Recent Initiatives
  • Table 278 Bio-Rad Laboratories: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 279 Bio-Rad Laboratories: Product Portfolio
  • Table 280 Bio-Rad Laboratories: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
  • Table 281 GE Healthcare: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 282 GE Healthcare: Product Portfolio
  • Table 283 GE Healthcare: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
  • Table 284 Illumina: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 285 Illumina: Product Portfolio
  • Table 286 Illumina: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
  • Table 287 Qiagen N.V.: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 288 Qiagen N.V.: Product Portfolio
  • Table 289 Qiagen N.V.: Selected Recent Contracts / Projects / Programmes / News/ Mergers & Acquisitions
  • Table 290 Biocept: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 291 Biocept: Product Offerings
  • Table 292 Biocept: Recent Initiatives, 2017 - 2020
  • Table 293 Guardant Health: Headquarter, Founded, Employees, Company Type, Website, Business Segment
  • Table 294 Guardant Health: Product Offerings
  • Table 295 Guardant Health: Recent Initiatives, 2017 - 2020
  • Table 296 Other Notable Players in Cancer Biologics Therapy and Therapeutics Industry

Companies Profiled in the Report:

  • AbbVie Inc
  • Agilent Technologies, Inc.
  • Amgen
  • Bio-Rad Laboratories
  • Biocept
  • Eli Lilly and Company
  • F.Hoffman La Roche
  • GE Healthcare
  • GlaxoSmithKline
  • Guardant Health
  • Illumina
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer
  • Qiagen N.V.

List of Companies Mentioned in the Report:

  • Abbvie
  • Abz-Pharma GmbH
  • Accord Healthcare Ltd
  • Alexion Pharmaceuticals Inc
  • Amgen
  • Apotex Europe Bv
  • AstraZeneca
  • Berlex Inc
  • Biocon
  • Biogen Inc
  • BioPartners GmbH
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Celltech, UCB.
  • Celltrion Healthcare Hungary Kft.
  • Centocor Ortho Biotech Products LP
  • Chugai Pharmaceutical Co., Ltd
  • Coherus Biosciences
  • Dyax Corp.
  • Genmab A/S
  • Genzyme Corp.
  • Guardant Health
  • Hexal Ag
  • Hospira UK Limited
  • Janssen Biotech Inc
  • Kyowa Hakko Kirin
  • Medarex
  • Medice Arzneimittel Putter GmbH & Co. Kg
  • MedImmune
  • Merck
  • Millennium Pharmaceuticals Inc
  • MSD
  • Mylan
  • Novartis
  • NovImmmune
  • Pfizer
  • Qiagen
  • Ratiopharm GmbH
  • Ratiopharm GmbH
  • Regeneron Pharmaceuticals
  • Roche
  • Samsung Bioepis
  • Sandoz GmbH
  • Sanofi
  • Stada Arzneimittel Ag
  • Sysmex Inostics
  • Taimed Biologics
  • Teva GmbH
  • United Therapeutics Corporation
  • Wyeth Pharmaceuticals

List of Organizations Mentioned in the Report:

  • American Cancer Society
  • Angeles Clinic and Research Institute
  • British Columbia Cancer Agency
  • Cancer Research Institute
  • Croatian government
  • Department of Anatomic Pathology and the Department of Medical Oncology
  • Drug Controller General of India
  • European Medicines Agency
  • European Union
  • Food and Drug Administration
  • Government of Romania
  • Hospital Clínic
  • Institut Gustave Roussy (Villejuif, France)
  • National Cancer Institute (NCI)
  • Netherlands Cancer Institute (Amsterdam)
  • Organization for Economic Co-operation and Development
  • Serbian government
  • Spanish National Cancer Research Center (CNIO)
  • The Christie Hospital (NHS Foundation Trust)
  • The Cyclotron Centre Bronowice (CCB)
  • The National Institutes of Health
  • The Paula Stradinja University Hospital
  • United Nations
  • University of Leeds in the United Kingdom
  • University of Texas Southwestern Medical Center
  • World Health Organization